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Centrins are a subfamily within the superfamily of
Ca21-modulated proteins that play a fundamental role
in centrosome duplication and contraction of centrin-
based fiber systems. We examined the individual molec-
ular properties of yeast, green alga, and human cen-
trins. Circular dichroism spectroscopy revealed a
divergent influence of Ca21 binding on the a-helical con-
tent of these proteins. Ca21-free centrins were elongated
in shape as determined by size exclusion chromatogra-
phy. The presence of Ca21 and binding peptide resulted
in more spherical shaped centrins. In contrast to yeast
calmodulin, centrins formed multimers in the Ca21-
bound state. This oligomerization was significantly re-
duced in the absence of Ca21 and in the presence of
binding peptide. The Ca21-dependent polymerization of
the green alga Scherffelia dubia centrin (SdCen) re-
sulted in a filamentous network. This molecular prop-
erty was mainly dependent on the amino-terminal sub-
domain and the peptide-binding site of SdCen. Finally,
we analyzed whether SdCen and Cdc31p-SdCen hybrid
proteins functionally substitute for the Saccharomyces
cerevisiae centrin Cdc31p. Only hybrid proteins contain-
ing the amino-terminal subdomain or the third EF-hand
of SdCen and the other subdomains from Cdc31p were
functional in vivo.
The microtubule-organizing center organizes the number,
direction, and polarity of microtubules in eukaryotic cells. Mi-
crotubule-organizing centers differ in appearance from species
to species and are known as the centrosome, basal body, or
spindle pole body (SPB)1 (for review, see Refs. 1–3). Besides
g-tubulin (4, 5), members of the centrin protein family are
associated with many microtubule-organizing centers in phy-
logenetically diverse organisms (6). These include algae and
protists (7, 8), higher plants (9), yeast (10, 11), and mammals
(12, 13). Comparative analysis of centrin protein sequences
revealed that they are a closely related family within the larger
superfamily of Ca21-modulated proteins (for review, see Ref.
14). This superfamily includes calmodulin, troponin C, parval-
bumin, S-100 protein, myosin light chain, and vitamin D-de-
pendent Ca21-binding protein (13, 15, 16). In general, centrins
are acidic centrosomal or contractile fiber-associated proteins
of ;20 kDa that contain four helix-loop-helix subdomains, the
so-called EF-hands, which represent potential Ca21-binding
sites.
The amino-terminal subdomain is the most distinctive and
variable region of centrins (see Fig. 1). It is about two or three
times as long as the corresponding subdomain of related EF-
hand proteins such as Saccharomyces cerevisiae calmodulin. It
has been suggested that the amino-terminal subdomain of cen-
trins confers their functional diversity (17, 18). The EF-hands
of centrins are in exact sequence register with those found in
calmodulin (see Fig. 1). Due to their high homology and iden-
tical domain architecture, the tertiary structure of centrins
may be similar to that of calmodulins. Whereas for centrins no
three-dimensional structural data are available so far, the crys-
tal structure of Ca21-coordinated (holo) vertebrate calmodulin
revealed a dumbbell-shaped protein with two globular do-
mains, each composed of two EF-hands (for review, see Ref. 19).
The two globular domains were connected in trans configura-
tion by a long extended central a-helix (20). NMR spectroscopy
studies of the Ca21-bound calmodulin indicated that the cen-
tral helix is highly mobile in solution and acts as a flexible
linker (21, 22).
In green algae, such as Chlamydomonas reinhardtii and
Scherffelia dubia, centrin participates in the contraction of
fibers of the nucleus-basal body connectors and of fibers inter-
connecting the basal bodies (23–25). Centrin is a major compo-
nent of these fibers, and binding of Ca21 to centrin causes
shortening of the fibers even in the absence of ATP. This fiber
contraction also plays a fundamental role in microtubule sev-
ering at the time of flagella excision in Chlamydomonas (26).
The centrin-based contraction mechanism is different from the
sliding filament mechanism of muscle contraction: the centrin-
containing fibers twist and supercoil to form electron-dense
globules as they contract (27). C. reinhardtii centrin (CrCen)
has been studied biochemically after purification from C. rein-
hardtii (15) and after high level expression from Escherichia
coli (28). CrCen has four Ca21-binding sites, two with higher
and two with lower affinity (28).
In S. cerevisiae, centrin is encoded by the essential CDC31
gene (11, 29). Temperature-sensitive mutants of CDC31 are
defective in the first step of SPB duplication, the formation of
the satellite that is assumed to be a precursor of newly formed
SPB (30). The phenotype of cdc31 mutants and the localization
of Cdc31p at exactly the site where SPB duplication occurs
suggest that Cdc31p plays an important role in the cell cycle-
dependent initiation of SPB duplication (10, 29). Cdc31p binds
to a short amino acid sequence within the central portion of the
SPB component Kar1p (31, 32). Kar1p is associated with the
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same SPB substructure as Cdc31p (29, 32) and is the only
known structural component that interacts with a centrin.
Cdc31p binding to Kar1p is not absolutely required for SPB
duplication since certain mutations in CDC31 suppress the
deletion of the normally essential KAR1 gene (33). The cloning
of human centrins has unexpectedly revealed two highly re-
lated isogenes (12, 13). Immunofluorescence experiments have
indicated that they may be associated with centrioles (13) or
with the pericentriolar material (12).
In this paper, we provide the first comparative biochemical
analysis of the centrins from S. cerevisiae (Cdc31p), S. dubia
(SdCen), Homo sapiens (HsCen1 and HsCen2), and S. cerevi-
siae calmodulin (ScCaM). Their biochemical and biophysical
properties were analyzed under standard conditions in order to
achieve comparable data. In addition, we investigated whether
SdCen and Cdc31p-SdCen hybrid proteins can functionally
replace Cdc31p in vivo. We have obtained evidence that cen-
trins and ScCaM differ in their Ca21-dependent properties and
that centrins show a remarkable biochemical divergence.
EXPERIMENTAL PROCEDURES
Media, Bacterial and Yeast Transformation, and DNA Techniques—
Media for growth of yeast were prepared as described (34). Yeast and E.
coli cells were transformed according to published protocols (35, 36).
The nucleotide sequence of all PCR constructs was determined by the
chain termination method (37). All other DNA manipulations were
performed as described (38).
Construction of Plasmids—Plasmids are listed in Table I. CMD1 (39),
CDC31 (11), HsCEN1 (13), HsCEN2 (12), and SdCEN (17) were ampli-
fied by PCR using plasmids pSM61 (32), pSM14 (29), pSK333A, AG24
and pKsdCen, respectively, as templates. The sense primers were de-
signed such that the translation initiation codon (ATG) of the five genes
formed part of a NdeI restriction site. The antisense primers were
located ;50 nucleotides downstream of the stop codon and introduced
an EcoRI or a PstI restriction site. The PCR products were subcloned
into the expression vector pT7-7 (40).
Construction of CDC31-SdCEN Gene Fusions—The sites of gene
fusion are indicated in Fig. 1 (arrows). CDC31-SdCEN gene fusions
were constructed by recombinant PCR. All gene fusions carried the
promoter and the terminator regions of CDC31 (11). Primers CDC31-I
(59-TAACCCAAAGCTTGATGTATTTCTCTCTAGTA-39) and CDC31-B
(59-TAACCCAGAGCTCGCTCGAAATGGCTATTGAACTCTAG-39), car-
rying a HindIII and a SacI restriction site (underlined), respectively,
were used for the subcloning of the PCR products into the yeast E. coli
shuttle vector pRS425 or pRS426 (41). The CDC313-CMD1 gene fusion
was constructed similarly.
CDC31 and SdCEN under the Control of the GAL1 Promoter—-
CDC31 was amplified by PCR. The sense primer CDC31-BamHI intro-
duced a BamHI restriction site just upstream of the ATG start codon of
CDC31. The PCR product was subcloned into the yeast expression
vector pYES2 (Invitrogen) to give plasmid pSM59. SdCEN and Sd-
CENN-CDC31 were subcloned in a similar manner into pYES2 to give
pAH2 and pSM102, respectively.
Functionality and Expression of the CDC31-SdCEN Gene Fu-
sions—To test whether SdCEN and CDC31-SdCEN are functional in
yeast, we constructed ESM109 (Dcdc31::HIS3 pSM85), which has a
disruption of the chromosomal CDC31 gene and is maintained by
CDC31 on a URA3-based plasmid (pSM85). ESM109 did not grow on
plates of 5-fluoroorotic acid, which selects against the URA3 plasmid,
showing that CDC31 is essential for growth (29). However, ESM109
grew on 5-fluoroorotic acid when a second CDC31 gene was provided on
the LEU2-based plasmid pRS425-CDC31 (pSM234). This property of
ESM109 was used to test whether CDC31-SdCEN gene fusions on
plasmid pRS425 provided CDC31 function.
Alternatively, strain ESM56 (32) was used for the complementation
test. Strain ESM56 carries CDC31 under the control of the MET3
promoter (42) integrated into the LEU2 locus. The chromosomal CDC31
gene is disrupted by the HIS3 gene. ESM56 cells grow at a normal rate
on minimal medium without methionine. The addition of methionine to
the growth medium represses CDC31 expression from the MET3 pro-
moter, causing cell cycle arrest after Cdc31p depletion. The presence of
an additional copy of CDC31 under the control of its own promoter
restored growth on plates containing methionine. This property of
ESM56 was used to test the functionality of CDC31-SdCEN gene fu-
sions. ESM56 was transformed with plasmids pSM144 and pSM155 to
pSM159 (Table I), with selection being made on synthetic minimal
plates containing adenine, lysine, and tryptophan (SM1ALT). Growth
on the repressing synthetic complete plates containing 2 mM methio-
nine (SC1Met) indicated that the CDC31-SdCEN gene fusion on plas-
mid pRS426 provided CDC31 function.
The functionality ofGAL1-SdCEN orGAL1-SdCENN-CDC31 in pYES2
was tested after transformation in ESM56 by growth on SC1Met me-
dium containing either 2% glucose (repression of theGAL1 promoter) or
2% galactose/raffinose (induction of the GAL1 promoter). Plasmid
pSM59 (GAL1-CDC31) was used as a positive control, and plasmid
pYES2 (GAL1 promoter) was used as a negative control.
The expression of CDC31-SdCEN gene fusions from the CDC31
promoter was tested in ESM56. ESM56 cells carrying CDC31-SdCEN
on plasmid pRS426 were grown on SM1ALT medium at 30 °C over-
night. The cultures were then diluted 1:10 with SC1Met or SM1ALT
medium. Cells were incubated for 6 h at 30 °C. Cell extracts were
prepared as described (43). Protein extracts (80 mg of protein) (44) were
separated by SDS-PAGE and then transferred onto nitrocellulose mem-
branes. Cdc31p-SdCen fusion proteins were detected with antibodies
against Cdc31p (29). The Cdc31p signal in ESM56 cells grown in the
presence of methionine reflects the steady-state level of plasmid-en-
coded Cdc31p-SdCen fusion proteins. The signals of cells grown on
SM1ALT medium are the sum of MET3-CDC31 and plasmid-encoded
CDC31-SdCEN.
Protein Purification—TY medium (5 g of NaCl, 5 g of yeast extract,
10 g of Bacto-tryptone/liter) (36 liters; 100 mg/ml ampicillin) was inoc-
ulated with E. coli BL21(DE3) cells carrying centrins or calmodulin
genes in expression vector pT7-7. Cells were incubated at 37 °C to an
absorbance at 600 nm of 0.4. Isopropyl-b-D-thiogalactopyranoside (0.5
mM) was added for 2 h at 30 °C to induce the synthesis of the recombi-
nant proteins. The cell pellet was washed with 400 ml of wash buffer (25
mM Tris, 17 mMHCl, 400 mMNaCl, 2 mM CaCl2, 5% glycerol, 5 mM DTT,
2.5 mM phenylmethylsulfonyl fluoride, and 2.5 mM p-aminobenzami-
dine). Cells were resuspended in 360 ml of lysis buffer (50 mM Tris, 34
FIG. 1. Sequence alignment of centrins and ScCaM. The amino acid sequences of HsCen1 (13), HsCen2 (12), SdCen (17), Cdc31p (11, 29),
and ScCaM (39) are aligned. Centrins are divided into an amino-terminal subdomain, EF-hands I and II (which are separated from EF-hands III
and IV by a short linker region), and the carboxyl-terminal subdomain. Each EF-hand consists of an E-helix, the Ca21-binding site, and an F-helix.
Light gray amino acids indicate conserved residues within the EF-hands, whereas dark gray amino acids are involved in Ca21 coordination. The
underlined amino acid sequence of SdCen was synthesized and used for competition experiments (see Fig. 7A). The arrows indicate the fusion sites
of Cdc31p-SdCen and Cdc31p-ScCaM hybrid proteins (see Figs. 7A and 8).
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mM HCl, 2 mM CaCl2, 0.005% Triton X-100, 1 mM EDTA, 4 mM DTT, 2
mM phenylmethylsulfonyl fluoride, and 2 mM p-aminobenzamidine) and
lyzed by sonication. The lysate was centrifuged at 16,000 3 g for 15 min
at 4 °C. The supernatant was collected, and the pellet was re-extracted
as described above. The pooled supernatants were supplemented with 2
mM DTT, 1 mM phenylmethylsulfonyl fluoride, and 1 mM p-aminoben-
zamidine and incubated in a boiling water bath until the solution
reached 80 °C. The solution was cooled in a CO2/ethanol bath to 10 °C.
Denatured proteins were removed by centrifugation. All following chro-
matography steps were performed at 4 °C.
The supernatant was incubated with 150 ml of DEAE-cellulose (Sig-
ma) equilibrated with AEC buffer (50 mM Tris, 34 mM HCl, and 1 mM
DTT) for 2 h. After washing the DEAE-cellulose with 350 ml of AEC
buffer, a linear gradient (total volume of 1 liter) from 0 to 1 M NaCl in
AEC buffer was applied. Fractions eluting from 100 to 350 mM NaCl
were pooled; adjusted to a final concentration of 1.5 M NaCl, 5 mM
CaCl2, and 13% glycerol; and applied to a 75-ml phenyl-Sepharose HP
column (Pharmacia Biotech Inc.) equilibrated with HIC buffer (50 mM
Tris, 34 mM HCl, 1.5 M NaCl, 5 mM CaCl2, 10% glycerol, and 1 mM DTT).
The column was washed with HIC buffer, and bound proteins were
eluted with HIC-E buffer (10 mM Tris, 6.8 mM HCl, 5 mM EGTA, 10%
glycerol, and 1 mM DTT).
The pooled fractions were concentrated by ultrafiltration (Millipore
Corp.) to 2 ml and applied to a Superdex 75 HiLoad 16/60 column
(Pharmacia Biotech FPLC system) equilibrated with 50 mM Tris, 34 mM
HCl, 100 mM NaCl, 10% glycerol, 1 mM DTT, and 0.5 mM EGTA.
Fractions containing the recombinant protein were concentrated to 1.5
mM.
Analytical Techniques—Protein concentration was determined using
bovine serum albumin as a standard (45). Alternatively, the molar
extinction coefficient was used to calculate the concentration. We de-
termined the molar extinction coefficient at l 5 276 nm of Cdc31p
(18,751 Da) to be 7250 M21 cm21 based on a mixture of five tyrosine and
nine phenylalanine residues measured in the presence or absence of 6
M guanidium hydrochloride. The concentration of peptides was deter-
mined using the tryptophan absorbance at l 5 280 nm.
CD Spectroscopy—CD measurements were performed using a Jobin
Yvon Mark IVCD spectrometer. Measurements using 0.1 mg/ml protein
were first recorded in 10 mMMOPS, 5 mM KOH, 50 mM KCl, and 0.5 mM
EGTA at 20 °C in a 10-mm path cuvette. Ca21 (2 mM) was added,
followed by a second recording. The average of 10 spectra from 198 to
240 nm with 0.1-nm spacing was used for the calculations of a-helical
content with the CD package of CONTIN (46). The a-helical contents
are means of at least four independent experiments.
Determination of the Apparent Molecular Masses of Centrins and
ScCaM—The apparent molecular mass (AMM) was determined by size
exclusion chromatography (Superdex 75 PC 3.2/30 column, Pharmacia
Biotech Smart System). The column was calibrated with globular pro-
teins (bovine serum albumin (66 kDa; KD 5 0.123), egg albumin (45
kDa; KD 5 0.176), carbonic anhydrase (29 kDa; KD 5 0.262), and RNase
A (13.7 kDa; KD 5 0.384)) at a flow rate of 6.25 mm/min at 20 °C with
10 mM MOPS, 5 mM KOH, 100 mM NaCl, and 1 mM DTT in the absence
(0.5 mM EGTA) or presence of 0.1 mM Ca21. Blue dextran was used to
determine the void volume (V0 5 878 ml), and acetone to estimate the
pore volume (VP 5 1525 ml). The distribution coefficient (KD) was
calculated using the equation KD 5 VP
21(VR 2 V0), where VR is the
retention volume. The AMMs were determined with the equation
AMM 5 133.33 e(25.9155 KD) (r 5 0.9976). In some experiments, the
EF-hand proteins were preincubated with a 4-fold molar excess of
Kar1p peptide (KKRELIESKWHRLLFHDKK; centrins) or Spc110p
peptide (RRLSFKTVAWLVLASVRMKRI; ScCaM) for 10 min at 20 °C.
The Spc110p peptide contains a Leu to Trp exchange at position 10,
which does not influence the binding properties. All peptides were
synthesized by the Max-Planck-Institut Peptide Service.
Association Studies—Centrins and ScCaM were incubated at a pro-
tein concentration of 1.5 mM with 10 mM Ca21 in P buffer (50 mM Tris,
34 mM HCl, 100 mM NaCl, 10% glycerol, and 1 mM DTT). For the
inhibition of SdCen polymerization by peptides, a 4-fold molar excess of
Kar1p peptide, a peptide corresponding to the 20 amino acids of the
amino-terminal subdomain of SdCen (MSYRKAASARRDKAKTRSAG)
or yeast a-factor (WHWLQLKPQPMY), was incubated with SdCen for
10 min at 20 °C before the addition of 10 mM Ca21. The samples were
centrifuged at 10,000 3 g for 15 min at 4 °C. The sediment was washed
with 10 mM Ca21 in P buffer and centrifuged as described above, and
the remaining sediment was washed with 10 mM EGTA in P buffer and
finally dissolved in 2% SDS. Fractions were analyzed by SDS-PAGE
and densitometry (Howtek Scanmaster 3).
Formation of Filamentous Structures—The polymerization reaction
TABLE I
Plasmids
Plasmid Construction Source
AG24 HsCEN2 M. Bornens
pAH2 SdCEN in pYES2: GAL1-SdCEN This study
pKSdCen SdCEN Ref. 17
pRS425 2 mm, LEU2-based yeast E. coli shuttle vector Ref. 41
pRS426 2 mm, URA3-based yeast E. coli shuttle vector Ref. 41
pSK333A HsCEN1 Ref. 13
pSM5 CDC31 in pT7–7 Ref. 29
pSM14 CDC31 in pBluescript SK Ref. 29
pSM56 CDC31 in pRS426 This study
pSM59 CDC31 in pYES2: GAL1-CDC31 This study
pSM61 CMD1 in pUC18 Ref. 32
pSM71 CMD1 in pT7–7 Ref. 32
pSM85 Yeast E. coli shuttle vector carrying URA3 ADE3 CDC31 This study
pSM102 SdCENN-CDC31 in pYES2: GAL1-SdCENN-CDC31 This study
pSM144 CDC31N-SdCEN in pRS426 This study
pSM155 CDC311-SdCEN in pRS426 This study
pSM156 CDC312-SdCEN in pRS426 This study
pSM157 CDC313-SdCEN in pRS426 This study
pSM158 CDC314-SdCEN in pRS426 This study
pSM159 CDC31C-SdCEN in pRS426 This study
pSM160 CDC31N-SdCEN in pRS425 This study
pSM161 CDC311-SdCEN in pRS425 This study
pSM162 CDC312-SdCEN in pRS425 This study
pSM163 CDC313-SdCEN in pRS425 This study
pSM164 CDC314-SdCEN in pRS425 This study
pSM165 CDC31C-SdCEN in pRS425 This study
pSM169 SdCEN in pT7–7 This study
pSM170 CDC31N-SdCEN in pT7–7 This study
pSM234 CDC31 in pRS425 This study
pSM248 HsCEN1 in pT7–7 This study
pSM293 CDC313-CMD1 in pRS426 This study
pSM308 SdCENN-CDC31 in pT7–7 This study
pT7–7 Phage T7 promoter Ref. 40
pTP6 HsCEN2 in pT7–7 This study
pYES2 2 mm, URA3-based yeast E. coli shuttle vector GAL1 promoter Invitrogen
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was induced on a nickel grid coated with Formvar (placed in the slot of
a multichamber dialysis apparatus) with a gradient from 0 to 1 mM
Ca21 in P buffer over 3 h at 20 °C. The grids were washed with 1 mM
Ca21 or 10 mM EGTA in P buffer. The samples were prepared for
electron microscopy using a positive staining procedure. Grids were
incubated with lead citrate, washed with H2O, and than stained with
2% uranyl acetate in 70% methanol. Finally, the grids were washed
with 70% methanol and incubated again with lead citrate.
RESULTS
Purification of ScCaM, Cdc31p, SdCen, HsCen1, and
HsCen2—The strategy (Fig. 2A) for the purification of ScCaM,
Cdc31p, SdCen, HsCen1, and HsCen2 is based on published
protocols (28, 29, 47, 48); however, it was optimized to achieve
purification of all five EF-hand proteins under identical condi-
tions. We obtained ;100 mg of pure protein from 36 liters of E.
coli culture after a 35-fold enrichment, with a yield of 40%. All
proteins were at least 99% pure as judged by one- and two-
dimensional gel electrophoresis (Fig. 2, B and C) as well as by
the absence of tryptophan fluorescence. The latter could be
used as purity criteria since centrins and ScCaM do not contain
intrinsic tryptophan residues. We conclude that our protocol is
suitable for the purification of four centrins and ScCaM, sug-
gesting that it may also be useful for the purification of other
EF-hand proteins.
Ca21-induced Conformational Changes—Analysis of the EF-
hand protein spectrin revealed that EF-hands change their
conformation upon Ca21 binding (49). Therefore, we investi-
gated by CD spectroscopy and size exclusion chromatography
whether Ca21 binding to centrins induces conformational
changes. The CD spectra were first recorded for the Ca21-free
apo form of the proteins. Ca21 was then added to obtain the
holo forms, which were analyzed by a second CD recording (Fig.
3). The a-helical values were calculated, with 69% for ScCaM,
42% for Cdc31p, 50% for SdCen, 37% for HsCen1, and 42% for
HsCen2. A decrease in a-helical content upon Ca21 binding
was measured for ScCaM (10%) and HsCen1 (12%), while
Cdc31p showed an increase by 12% (Fig. 3). No change in
a-helical content was observed for HsCen2 and SdCen, which
does not exclude Ca21-induced conformational changes. How-
ever, it indicates that the sum of the structural elements con-
tributing to the CD spectrum remained constant.
Conformational changes accompanied by an alteration in
molecular shape are detectable by size exclusion chromatogra-
phy as a change in the AMM. Such studies require a highly
reproducible size exclusion chromatography system. Using
standardized conditions, we could measure the AMMs of cen-
trins with an accuracy of 60.2 kDa. At a protein concentration
at or below 10 mM, all apo forms of the four centrins and ScCaM
revealed an AMM that was ;1.7-fold higher than the calcu-
lated molecular mass (Table II). It is known that vertebrate
calmodulin resembles an elongated molecule (21, 22) and that
the long axis of the molecule causes a defined overestimation of
the AMM when globular proteins are used for column calibra-
tion (28). Considering the homology between calmodulins and
centrins, it is most likely that centrins are also elongated
molecules, explaining their behavior on sizing columns.
We determined the AMMs of centrins and ScCaM in their
Ca21-bound state (holo form, Table II). Since comparison of the
holo and apo forms may indicate conformational changes, we
expressed the relative AMM (ratio of the holo to apo forms) in
Fig. 4A. The horizontal line at 1.0 indicates the relative AMM
of the apo forms. While the relative AMM increased for ScCaM
(Fig. 4A, indicated by the bar above the horizontal line), it
decreased for all centrins (indicated by the bars below the
horizontal line). Within the centrin family, the relative Ca21-
induced change was lowest for HsCen2, followed by HsCen1
and Cdc31p, and was most pronounced for SdCen (Fig. 4A).
These alterations were specific for Ca21 since Mg21 did not
influence the AMM (data not shown). Since the alterations in
the AMM are likely the result of conformational changes (see
“Discussion”), we suggest that centrins and calmodulins are
differently influenced by Ca21 binding, resulting in a more
extended conformation for ScCaM and a more compact one for
centrins. Interestingly, centrins bound in the presence of Ca21
to the hydrophobic phenyl-Sepharose column and were eluted
by the removal of Ca21 (Fig. 2A), suggesting that centrins,
similar to calmodulins, expose a hydrophobic surface in their
more compact Ca21-bound form.
Influence of Peptide Binding—The four centrins, but not
FIG. 2. Purification scheme and analysis of the purified EF-
hand proteins by gel electrophoresis. A, flow diagram of the puri-
fication of centrins and ScCaM. B, analysis of the purified centrins and
calmodulin. Purified proteins (1 mg each) were analyzed on a 15%
SDS-polyacrylamide gel. The gel was stained with Coomassie Blue G.
Molecular mass standards were b-galactosidase, phosphorylase b, bo-
vine serum albumin, fumarase, carbonic anhydrase, b-lactalbumin,
a-lactalbumin, and aprotinin. C, estimation of the isoelectric point
(IEF) values of centrins and ScCaM. A mixture of purified ScCaM,
Cdc31p, SdCen, HsCen1, and HsCen2 was analyzed by isoelectric fo-
cusing using a linear immobilized pH gradient from pH 4 to 6. This gel
was then layered on top of a 19% Tris/urea-SDS-polyacrylamide gel.
Electrophoresis was performed simultaneously with 1 mg of ScCaM,
Cdc31p, SdCen, HsCen1, and HsCen2. The gel was stained with Coo-
massie Blue G. The pI values of ScCaM, Cdc31p, SdCen1, HsCen1, and
HsCen2 were 4.32, 4.51, 4.85, 4.92, and 5.05, respectively. These deter-
mined pI values were 0.25 pH units above the calculated values.
FIG. 3. Circular dichroism spectra of the apo and holo forms of
ScCaM and centrins. The CD spectra were recorded at a protein
concentration of 0.1 mg/ml at 20 °C in the presence of EGTA (2Ca21) or
after the addition of CaCl2 (1Ca
21).
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ScCaM, bind with high affinity to a small peptide correspond-
ing to the Cdc31p-binding site of Kar1p (32).2 ScCaM, however,
interacts with a peptide corresponding to the ScCaM-binding
site of the SPB component Spc110p (50, 51, 60). We used these
peptides for the further characterization of centrins. As an
example of our analysis, the fractionation of Cdc31p with and
without the Kar1p peptide by size exclusion chromatography is
shown in Fig. 5. The chromatograms were recorded at two
wavelengths (276 and 295 nm). This was useful since the Kar1p
peptide, but not the centrins, contain the amino acid trypto-
phan, which is detected by absorbance at 295 nm. Therefore,
the 276 nm signal mainly results from Cdc31p, while the 295
nm signal indicates the position of the Kar1p peptide. In this
experiment, Cdc31p eluted from the size exclusion column with
a distribution coefficient (KD) of 0.23 (Fig. 5A, curve 1). The KD
is inversely related to the AMM (see “Experimental Proce-
dures”). The addition of the Kar1p peptide was accompanied by
a shift of the Cdc31p signal (276 nm) to a higher KD and by an
increase in absorbance (Fig. 5A, compare curves 1 and 2). In
addition, a tryptophan signal (295 nm) (Fig. 5A, compare curves
3 and 4) with the same KD as Cdc31p was observed, suggesting
that Cdc31p forms a complex with the peptide. The unbound
Kar1p peptide is not seen on the chromatogram since its KD is
above 0.4. Corresponding peak fractions were analyzed by
SDS-PAGE, confirming that the Kar1p peptide cofractionated
with Cdc31p (Fig. 5, compare B (no peptide) with C (Cdc31p
peptide complex)). No Cdc31p-Kar1p peptide complex was ob-
tained when Cdc31p was in its Ca21-free apo state, suggesting
that binding of the Kar1p peptide to Cdc31p is Ca21-depend-
ent. Similarly, no Cdc31p peptide complex was observed with
control peptides, e.g. a-factor (data not shown).2 B. M. Geier, H. Wiech, and E. Schiebel, submitted for publication.
TABLE II
Determination of the apparent molecular masses of centrins and ScCaM
The calculated molecular mass is based on the deduced amino acid sequences (see Fig. 1). The AMM was determined by size exclusion
chromatography with an accuracy of 60.2 kDa (n 5 5). The AMMs of the apo, holo, and peptide-bound holo forms of centrins and ScCaM were
analyzed at protein concentrations of 2.5, 5, and 10 mM. The AMM remained constant at these protein concentrations.
Protein CMMa
AMM
Apo Holo Holo 1 peptide
kDa kDa
ScCaM 16.74 28.2 33.4 24.9
Cdc31p 18.75 33.3 27.8 28.4
SdCen 19.33 32.8 23.1 24.4
HsCen1 19.57 35.3 33.4 29.7
HsCen2 19.74 34.2 33.6 28.8
a CCM, calculated molecular mass.
FIG. 4. Relative change in apparent molecular mass of ScCaM
and centrins upon Ca21 and peptide binding. The AMMs (listed in
Table II) of ScCaM and centrins were analyzed by size exclusion chro-
matography at a protein concentration of 10 mM. The ratios of the
AMMs of the holo to apo forms (A) (AMM (holo)/AMM (apo)) and of the
peptide-bound holo to holo forms (B) (AMM (holo 1 peptide)/AMM
(holo)) are shown.
FIG. 5. Interaction of Cdc31p with Cdc31p-binding peptide of
Kar1p. A, Cdc31p (10 ml of a 100 mM solution) in the holo state in the
presence (curves 2 and 4) or absence (curves 1 and 3) of the Kar1p
peptide was analyzed by size exclusion chromatography. The distribu-
tion coefficient (KD) is inversely related to the AMM. The absorbances
at 276 nm (curves 1 and 2) and 295 nm (curves 3 and 4) were recorded.
At 276 nm, Cdc31p and the Kar1p peptide were detected, and at 295
nm, only the Kar1p peptide was detected. This was due to the absence
of tryptophan in Cdc31p, whereas the Kar1p peptide contains this
amino acid. Peak fractions of the holo form (B) or of the holo form-Kar1p
peptide complex (C) were analyzed by 19% Tris/urea-SDS-PAGE and
stained with Coomassie Blue G.
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It has been shown that vertebrate calmodulin adopts a more
globular shape after binding to a peptide (21). Based on this
finding, we expected that binding of peptide to centrins and
ScCaM would result in a decrease in the AMM. The AMMs of
the centrin and ScCaM peptide complexes were determined by
size exclusion chromatography as described for Fig. 5A (Table
II) and compared with those of the holo forms (Fig. 4B). As
expected, binding of peptide caused a decrease in the relative
AMMs of ScCaM and the two human centrins. In contrast, a
slight increase was observed for Cdc31p and SdCen (Fig. 4B).
Our results suggest the formation of a more compact structure
upon peptide binding for ScCaM and the two human centrins
and a more extended conformation for Cdc31p and SdCen.
Ca21-dependent Formation of Polymers—Centrin is the ma-
jor component of the contractile filament system in green algae
(24, 52). Therefore, we studied the polymerization capability of
the different centrins and ScCaM. Increasing concentrations of
ScCaM and the four centrins were analyzed by size exclusion
chromatography. ScCaM was monomeric even at protein con-
centrations up to 1.5 mM and at Ca21 concentrations of 10 mM
(data not shown). However, centrins formed multimers in the
holo state above a protein concentration of 10 mM (Fig. 6, holo).
The formation of multimeric structures was strongly reduced
by peptide (Fig. 6, holo 1 peptide) or by the removal of Ca21
(Fig. 6, apo). In summary, a clear difference between ScCaM
and centrins is the tendency of centrins to form multimers.
SdCen Forms Filamentous Networks—We investigated the
properties and the extent of centrin polymers. The four centrins
were incubated at a protein concentration of 1.5 mM and with a
100-fold higher Ca21 concentration (10 mM) as in Fig. 6. Large
polymeric structures were sedimented by low speed centrifu-
gation (10,000 3 g) (Fig. 7A). In contrast to the other centrins,
70% of SdCen was sedimentable after the addition of Ca21.
Only 14% of this precipitate was dissolved by washes with Ca21
buffer. However, 57% of the precipitate was solubilized by
EGTA, which specifically chelates Ca21. The remaining insol-
uble material was completely dissolved by SDS. Only a minor
fraction of HsCen1 was sedimented (16%), which was then
dissolved by Ca21 and EGTA. For Cdc31p and HsCen2, hardly
any precipitable material was obtained. None of the centrins
sedimented with 10 mM Mg21 (data not shown), indicating that
the formation of polymers is specific for Ca21.
The amino-terminal extension of one SdCen molecule may
interact with the peptide-binding site of another, thereby caus-
ing SdCen polymerization. We tested this hypothesis by ex-
changing the amino-terminal extension of Cdc31p with the
corresponding sequence of SdCen (Cdc31pN-SdCen) and vice
versa (SdCenN-Cdc31p). Interestingly, neither Cdc31pN-SdCen nor
SdCenN-Cdc31p formed polymeric structures after the addition
of Ca21 (Fig. 7A). We also investigated whether Ca21-induced
polymerization of SdCen was inhibited by a peptide corre-
sponding to the amino-terminal subdomain of SdCen (Fig. 1,
FIG. 6. Ca21-, concentration-, and peptide-dependent associa-
tion of centrins. The AMM (n 5 4) was determined using protein
concentrations of 15 mM, 150 mM, or 1.5 mM purified centrins in the
absence (apo) (white bars) or presence of Ca21 ions (holo) (dotted bars)
or the Kar1p peptide (holo 1 peptide) (black bars). Shown is the ratio of
the AMM (AMMd) at the outlined protein concentrations to the mono-
meric AMM (AMMmono; AMM at 10 mM concentrations of the apo, holo,
and peptide-bound holo forms in Table II).
FIG. 7. Ca21-dependent formation of SdCen polymers. A, cen-
trins were analyzed for their ability to form polymers at a protein
concentration of 1.5 mM in the presence of 10 mM Ca21. In the experi-
ment labeled SdCen 1 a-factor, a-factor was added before Ca21 ions. In
the experiment labeled SdCen 1 peptide, a synthetic peptide corre-
sponding to the amino-terminal subdomain of SdCen (underlined in
Fig. 1) was added before Ca21. The bars indicate the percentage of
centrin that was sedimented by centrifugation (10,000 3 g) after the
addition of 10 mM Ca21. The sedimented material was washed with 10
mM Ca21, 10 mM EGTA, and 2% SDS. The marked areas represent the
fractions of centrin that were solubilized under these washing condi-
tions. The amount of protein in the different fractions is shown as a
percentage of the total protein. B, shown is the filamentous network of
SdCen. Induction of a filamentous network was performed by slowly
increasing the Ca21 concentration from 0 to 1 mM. SdCen filaments
were analyzed by electron microscopy. Bar 5 0.5 mm. C, the filamentous
network in B was washed with 10 mM EGTA.
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underlined sequence), which is expected when the amino-ter-
minal subdomain of SdCen interacts with another SdCen mol-
ecule. In agreement with our model, the SdCen peptide reduced
SdCen polymerization by 65% (Fig. 7A, SdCen1 peptide). If the
amino-terminal subdomain of SdCen interacts with the same
site as the Kar1p peptide, the latter should inhibit the polym-
erization reaction. As suggested by the results of Fig. 6, the
addition of the Kar1p peptide inhibited SdCen polymerization
by 80% (data not shown). Inhibition was specific for the SdCen
and Kar1p peptides since similar concentrations of yeast a-fac-
tor hardly influenced SdCen polymerization (Fig. 7A, SdCen 1
a-factor).
We were interested in whether the polymerized form of Sd-
Cen consisted of filamentous structures. The polymerization
reaction was induced by slowly increasing the Ca21 concentra-
tion. SdCen polymers were then analyzed by electron micros-
copy. SdCen formed a network of filaments with a diameter of
;30 nm connected by crossing points of 50 nm (Fig. 7B). The
connecting filaments were solubilized by EGTA, whereas the
crossing points were resistant (Fig. 7C). Taken together, our
findings are consistent with a model in which the amino-ter-
minal subdomain of one SdCen molecule interacts with the
peptide-binding site of another SdCen molecule, thereby caus-
ing the formation of a filamentous network.
Functional Analysis of Subdomains—Although all centrins
bind with high affinity to the Cdc31p-binding site of Kar1p,2
our biochemical analysis revealed differences in the polymeri-
zation behavior as well as in the Kar1p peptide-induced change
in conformation. This raised the question whether centrins are
interchangeable in vivo. SdCen was chosen for complementa-
tion studies in S. cerevisiae since it binds with similar affinity
as Cdc31p to Kar1p2 and extends like Cdc31p upon peptide
binding (Fig. 4B).
Plasmid-encoded SdCEN and CDC31 were under the control
of the galactose-inducible GAL1 promoter. Whether GAL1-Sd-
CEN provides CDC31 function was tested in strain ESM56,
which carries the chromosomal CDC31 gene under the control
of the MET3 promoter. Since the MET3 promoter is repressed
by methionine (42), ESM56 cells are unable to grow on methi-
onine-containing medium unless CDC31 function is replaced
by GAL1-SdCEN. While ESM56 cells carrying GAL1-CDC31
grew well on the methionine/galactose plates, GAL1-SdCEN
cells did not grow, suggesting that SdCEN does not comple-
ment CDC31. We speculated that the polymerization of SdCen
may be responsible for the noncomplementation. To test this
possibility, SdCENN-CDC31 (SdCen with the amino-terminal
subdomain from Cdc31p), which encodes for a hybrid protein
that does not polymerize (Fig. 7A), was expressed in MET3-
CDC31 cells. As observed for SdCEN, SdCENN-CDC31 did not
complement the CDC31 depletion mutant either.
We exchanged each subdomain of Cdc31p with the corre-
sponding domain of SdCen (the arrows in Fig. 1 indicate the
fusion sites) in order to examine functional diversity. CDC31-
SdCEN fusions, expressed from the CDC31 promoter, were
tested for CDC31 function in strains ESM56 and ESM109.
ESM109 has a disruption of the chromosomal CDC31 gene and
is kept alive by CDC31 on a URA3-based plasmid. ESM109
cells do not grow on plates of 5-fluoroorotic acid, which selects
against the URA3 plasmid, unless CDC31 function is provided
on a separate LEU2-based plasmid. Since identical results
were obtained with both strains, only those for ESM109 are
shown (Fig. 8A). CDC31 function was provided only by the
CDC31N-SdCEN and CDC313-SdCEN constructs (Fig. 8A, sectors
N and 3). We further noticed that CDC31N-SdCEN cells (Fig. 8A,
sector N) grew slower in comparison with CDC313-SdCEN (sector
3) and CDC31 (sector Cdc31p) cells.
An explanation for the noncomplementation of some CDC31-
SdCEN constructs may be the instability of the fusion proteins.
To test this possibility, the expression of MET3-CDC31 of
ESM56 was repressed by methionine. This allowed the detec-
tion of Cdc31p-SdCen proteins after degradation of Cdc31p.
Most of the Cdc31p was degraded as indicated by ESM56 cells
carrying the control plasmid or CDC31C-SdCEN (Fig. 8B).
Cdc31pC-SdCen migrated differently than Cdc31p. The steady-
state level of the Cdc31p-SdCen proteins was similar or higher
in comparison with Cdc31p or functional Cdc31p3-SdCen
(Fig. 8B).
The third EF-hand is the most conserved subdomain within
the centrin family. Therefore, we investigated whether the
third EF-hand of Cdc31p can be exchanged with the corre-
sponding subdomain of ScCaM (CDC313-CMD1). Testing the
functionality in ESM109 revealed that CDC313-CMD1 did not
provide Cdc31p function (data not shown). In summary, our
results suggest that Cdc31p is a specialized protein adapted to
its specific functional requirements in S. cerevisiae.
DISCUSSION
We were interested in whether centrins involved in different
cell functions have distinct biochemical properties. Cdc31p
(centrosome duplication), SdCen (fiber contraction), HsCen1
and HsCen2 (unknown function), and ScCaM were purified
FIG. 8. SdCEN does not fulfill CDC31 functions. A, ESM109
(Dcdc31::HIS3 CDC31 on aURA3-based plasmid) was transformed with
the LEU2-based plasmid pRS425 (sector control) or with pRS425 car-
rying CDC31 (sector Cdc31p), CDC31N-SdCEN (sector N), CDC311-SdCEN
(sector 1), CDC312-SdCEN (sector 2), CDC313-SdCEN (sector 3),
CDC314-SdCEN (sector 4), or CDC31C-SdCEN (sector C). Growth of the
transformants was tested at 23 °C on 5-fluoroorotic acid plates. Growth
on 5-fluoroorotic acid plates indicates that the plasmid-encoded CDC31-
SdCEN gene fusion provided CDC31 function. B, shown is the expres-
sion of CDC31 and CDC31-SdCEN gene fusions. ESM56 contains the
CDC31 gene under the control of theMET3 promoter. ESM56 cells with
the control plasmid pRS426 (control) and with pRS426 carrying CDC31,
CDC31N-SdCEN, CDC311-SdCEN, CDC312-SdCEN, CDC313-SdCEN,
CDC314-SdCEN, or CDC31C-SdCEN were incubated in medium with or
without methionine. Cells extracts (80 mg of total protein) were then
analyzed by immunoblotting with anti-Cdc31p antibodies. After 6 h in
the repressing methionine medium, most of the MET3-CDC31 was
degraded (control, 1Met). Therefore, the Cdc31p signal of MET3-
CDC31 cells grown in methionine medium (1Met) corresponds to the
constitutively expressed, plasmid-encoded CDC31 or CDC31-SdCEN
gene.
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under identical conditions, and their biochemical properties
were examined.
Apo State and Ca21 Binding—So far, an a-helical value of
65% has been deduced from CD measurements only for CrCen
(28). Since CrCen and SdCen are 91% identical, the 50% a-hel-
ical content of SdCen may be explained by the different meth-
ods applied for a-helical content calculation. Alternatively,
CrCen may already form polymers at the protein concentra-
tions used (0.5 or 5 mg/ml) in the CrCen CD measurements,
although we ensured in our study that SdCen (0.1 mg/ml) and
the other centrins were in their monomeric forms. Using CD
spectroscopy, we could demonstrate that HsCen2 and SdCen
did not change their overall a-helical content upon Ca21 bind-
ing. This is no indication that Ca21 binding does not alter the
conformation of these centrins since Ca21-induced conforma-
tional changes were determined for CrCen by NMR (28) and for
SdCen by size exclusion chromatography (Fig. 4A). In contrast
to SdCen and HsCen2, Cdc31p showed a Ca21-induced increase
in a-helical content, whereas for ScCaM and HsCen1, a de-
crease was observed. The 10% decrease in a-helical content of
ScCaM was more pronounced than the 3% determined before
(47).
The apo forms of the four centrins and ScCaM revealed an
AMM ;1.7-fold higher than the calculated molecular mass.
Since globular proteins were used for column calibration, this
defined overestimation of the AMM suggests that centrins are
likely to be elongated molecules perhaps with a domain archi-
tecture similar to calmodulin. Alterations in the AMM were
observed upon Ca21 addition and peptide binding, which most
likely correspond to conformational changes in the proteins. We
favor this interpretation since the changes in the AMM of
ScCaM are in agreement with the conformational changes re-
ported for vertebrate calmodulin (21, 22). In addition, the AMM
alterations observed for centrins were the same at or below
protein concentrations of 10 mM, making it unlikely that these
AMM changes reflect an altered tendency of centrins to inter-
act transiently. Finally, the AMM at 10 mM was minimally
influenced by the ionic strength, excluding interactions with
the gel matrix of the sizing column.
Holo Form and Peptide Binding—Ca21 binding increased
the AMM of ScCaM, while the AMM of centrins decreased,
suggesting that centrins, in contrast to ScCaM, become more
compact. The orientation of the EF-hands to each other and of
the amino-terminal extension relative to the EF-hands may be
responsible for the Ca21-induced behavior of centrins. Calmod-
ulin shows a dumbbell-shaped molecule with two globular do-
mains arranged in trans configuration connected by a central
a-helix (22). It becomes more compact upon peptide binding,
with the two globular domains facing each other in a cis orien-
tation and the central helix disrupted by a flexible loop (22).
Such a change to a more compact conformation may already
occur in some centrins upon Ca21 binding, explaining the
strong Ca21-induced decrease in the AMMs of Cdc31p and
SdCen (Fig. 4A). Alternatively, the long amino-terminal sub-
domain of centrins moves closer to the EF-hands, resulting in a
more compact molecule. In any case, to understand the Ca21-
induced conformational changes of centrins, high resolution
structural studies are required.
The structure of calmodulin bound to the calmodulin-binding
domain of skeletal muscle myosin light chain kinase has been
solved. The extended structure of the holo form collapsed to a
more compact molecule folded around the peptide (21). Simi-
larly, ScCaM adopted a more compact conformation upon pep-
tide binding (Fig. 4B). Also, the AMMs of the two human
centrins decreased, suggesting that HsCen1 and HsCen2 bind
to the target peptide in a similar manner as calmodulin. In
contrast, the AMMs of Cdc31p and SdCen increased, which
may be explained by a very compact conformation in the holo
form, which expands to allow peptide binding.
Formation of a Centrin-based Filamentous Network—Cen-
trins, but not ScCaM, formed multimers in the presence of
Ca21 and at protein concentrations above 10 mM. Under our in
vitro conditions, Cdc31p had the lowest and SdCen had the
highest tendency to form multimers (Fig. 6). Large polymeric
structures of SdCen and HsCen1 were formed (SdCen, 70%;
and HsCen1, 16%), which were sedimentable by low speed
centrifugation (Fig. 7A). Since only large polymers sediment
under this condition, we can not exclude that the other centrins
form polymers that, however, are not as extended.
The formation of the SdCen polymers was dependent on the
properties of the amino-terminal subdomain as well as the
peptide-binding site. This conclusion is based on the following
observations. Purified SdCenN-Cdc31p and Cdc31pN-SdCen fusion
proteins did not form filaments, suggesting that neither the
amino-terminal subdomain of SdCen nor the peptide-binding
site is sufficient for the polymerization reaction (Fig. 7A). In
addition, a synthetic peptide corresponding to the amino-ter-
minal subdomain of SdCen inhibited the formation of SdCen
filaments (Fig. 7A). Since also the Kar1p peptide reduced the
formation of SdCen multimers (Fig. 6) and polymers, we favor
a model in which the amino-terminal subdomain of one SdCen
molecule interacts with the peptide-binding site of another,
thereby forming a homodimer. A third SdCen molecule then
interacts with either the free amino-terminal extension of the
SdCen homodimer or the free peptide-binding site. Linear Sd-
Cen polymers may interact to form thicker filaments.
In flagellate green algae, centrin is the major protein of
4–8-nm filaments (53, 54). In contrast, our SdCen filaments
were 30 nm thick, which may be the result of the artificial
polymerization conditions. However, our results show for the
first time that a purified centrin is able to form polymeric
structures. Additional structural proteins and molecular chap-
erones may be required for the formation of filaments observed
in vivo. Modifications of centrin, e.g. phosphorylation (54),
could also influence filament formation.
The centrin-based fiber systems contract via a mechanism
that involves filament supercoiling induced by Ca21 binding to
centrin (27). Consistent with a function in Ca21-dependent
fiber contraction, SdCen showed the most pronounced changes
in conformation upon Ca21 binding (Fig. 4A). We assume that
the SdCen subunits in the filaments behave in a similar way as
the SdCen monomer. Since the SdCen subunits are likely con-
nected via their amino-terminal subdomains, Ca21-induced
contraction of each SdCen subunit will result in a rapid short-
ening of SdCen filaments.
Contribution of Subdomains to Function—It has been shown
that CrCEN does not complement a temperature-sensitive al-
lele of CDC31 (55). In agreement with this result, SdCen did
not replace Cdc31p function in yeast. However, Cdc31p hybrids
with the amino-terminal subdomain or the third EF-hand from
SdCen did (Fig. 8A). The functionality of Cdc31pN-SdCen was
surprising since it had been suggested that the heterogeneous
amino-terminal subdomains confer the functional diversity
within centrins (17). However, CDC31N-SdCEN cells grew at a
slower rate in comparison with CDC31 cells (Fig. 8A), empha-
sizing the importance of the amino-terminal subdomain for
centrin function. The third subdomain corresponds to one of the
most conserved regions within centrins. Its importance in
Cdc31p function was revealed by an exchange of the third
EF-hand with the corresponding subdomain of ScCaM, result-
ing in an inactive hybrid protein. In contrast to centrins, the
related calmodulins are less discriminative. Human (56) and
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Schizosaccharomyces pombe (57) calmodulins support growth
of S. cerevisiae. We suggest that centrins, in contrast to cal-
modulins, are proteins adapted to their specific functional re-
quirements in each species.
In summary, centrins are most distinguishable from the
calmodulin family by their ability to form multimeric struc-
tures. While SdCen clearly forms polymers in vitro and in vivo
(58), it is not clear whether the other three centrins studied
form polymeric structures in vivo. Human centrioles contract
in response to the removal of divalent cations (59), a process
that may involve centrin filaments. Cdc31p is associated with
the half-bridge of SPB (29), which enlarges in the G1 phase of
the cell cycle (30). This may occur by Cdc31p polymerization.
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